Eternity in Medical Information -- Medisurf
Items 1 ~ 8 of 7, Page 1 of 1
Statement from Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on FDA’s continued confidence in the safety and effectiveness of the measles, mumps, and rubella (MMR) vaccine
2018 in Review: CDC Looks Back at the Year’s Most Pressing Health Threats
From the opioid overdose epidemic to foodborne disease outbreaks and antimicrobial resistance to the Ebola virus outbreak in the Democratic Republic of Congo (DRC), CDC worked around the clock ? and around the globe ? to protect Americans from health threats in 2018.
12.21.2018 Centers for Disease Control and Prevention
Merck Begins Rolling Submission of Licensure Application for V920 (rVSV G-ZEBOV-GP) to U.S. Food and Drug Administration
V920 is the Company's Investigational Vaccine for Ebola Zaire
11.13.2018 MERCK
FDA authorizes emergency use of first Ebola fingerstick test with portable reader
Today, the U.S. Food and Drug Administration announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Zaire ebolavirus).
Flu mutations in a single cell help to predict immune response
Genetic diversity of the virus may explain variability in how well a cell fights back.
10.26.2018 Nature News by Carrie Arnold
Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
ABBOTT PARK, Ill., Oct. 25, 2018 /PRNewswire/ Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has cleared its next-generation Influenza A & B 2 and Strep A 2 molecular assays for point-of-care testing1,2. These new assays enable the fastest-ever3 time to molecular influenza A & B and Strep A results at the point of care.4 Currently available on the ID NOW™ platform (formerly Alere i), both assays have been granted a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver.
10.25.2018 Abbott
Flu vaccine reduces risk of flu hospitalization among pregnant women
Over the course of six flu seasons, getting a flu shot reduced a pregnant woman"s risk of being hospitalized from flu by an average of 40 percent.
10.11.2018 Centers for Disease Control and Prevention (CDC)